News » MHRA alert » Pantoprazole 40mg gastro-resistant tablets alert
January 31st 2024
Cadila Pharmaceuticals (UK) Limited has issued an alert relating to a barcoding error on eight batches of pantoprazole 40mg gastro-resistant tablets. Batches are not being recalled
When scanned, the EAN barcode identifies the product as bicalutamide 150mg tablets. The other product details on the carton, including the name, strength and pharmaceutical form of the medicine are correct. The Global Trade Item Number (GTIN) code printed on the pack and included in the 2D falsified medicines directive (FMD) barcode is also correct.
The affected batches are:
| Batch No | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| ET571E3001 | May 2025 | 28 | 18/10/2023 |
| ET571E3002 | May 2025 | 28 | 26/09/2023 |
| ET571E3003 | May 2025 | 28 | 13/09/2023 |
| ET571E3004 | May 2025 | 28 | 13/09/2023 |
| ET571E3005 | Jun 2025 | 28 | 20/11/2023 |
| ET571E3006 | Jun 2025 | 28 | 17/01/2024 |
| ET571E3007 | Jun 2025 | 28 | 19/12/2023 |
| ET571E3008 | Jun 2025 | 28 | Not yet distributed |
Dispensary teams are advised not to use these batches of medicine in robotic or automated dispensing or stocking systems and to carry out manual dispensing and stocking, as appropriate.
No action is needed from patients.
For medical information enquiries please contact pharmacovigilance-eu@cadilapharma.com or telephone: +44 1217901596
For stock control enquiries please contact info@crescentpharma.com or telephone: 01256 772730
